- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Boosting SARS-CoV-2 immunity in immunocompromised individuals ; day:19 ; month:12 ; year:2023 ; pages:1-2
Genes and immunity ; (19.12.2023), 1-2
- Urheber
-
Müller, Thomas R.
Buggert, Marcus
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41435-023-00219-6
- URN
-
urn:nbn:de:101:1-2024030321015591071244
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Müller, Thomas R.
- Buggert, Marcus
- SpringerLink (Online service)
Ähnliche Objekte (12)
Toxoplasma gondii infection in immunocompromised individuals
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants
Heterologous vaccine interventions: boosting immunity against future pandemics
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Supporting tumor therapy by exercise: boosting T cell immunity by myokines
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
“Immune Boosting” in the time of COVID: selling immunity on Instagram
SARS-CoV-2 immunity in animal models
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Toxoplasma gondii infection in immunocompromised individuals
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants
Heterologous vaccine interventions: boosting immunity against future pandemics
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Supporting tumor therapy by exercise: boosting T cell immunity by myokines
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
“Immune Boosting” in the time of COVID: selling immunity on Instagram
SARS-CoV-2 immunity in animal models
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Toxoplasma gondii infection in immunocompromised individuals
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants
Heterologous vaccine interventions: boosting immunity against future pandemics
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Supporting tumor therapy by exercise: boosting T cell immunity by myokines
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
“Immune Boosting” in the time of COVID: selling immunity on Instagram
SARS-CoV-2 immunity in animal models